Patents by Inventor Marilyn Monk

Marilyn Monk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for determining presence of cancer in a sample by assaying for expression of ECSA/DPPA-2 nucleotide sequences
    Patent number: 8354243
    Abstract: The invention relates to the discovery of known molecule “DPPA-2” and a so-called “cancer-testis antigen.” DPPA-2 is also a possible cancer stem cell marker. One can determine presence of cancer by assaying for the molecule, and also prevent or treat cancer via administration of the molecule.
    Type: Grant
    Filed: October 2, 2007
    Date of Patent: January 15, 2013
    Assignees: UCL Business plc, Ludwig Institute for Cancer Research
    Inventors: Thomas John, Suzanne Svobodova, Jonathan Cebon, Otavia L. Caballero, Marilyn Monk
  • METHOD FOR DETERMINING PRESENCE OF CANCER IN A SAMPLE BY ASSAYING FOR EXPRESSION OF DPPA-2 NUCLEOTIDE SEQUENCES
    Publication number: 20100210522
    Abstract: The invention relates to the discovery of known molecule “ESCA/DPPA-2” and a so-called “cancer-testis antigen.” ESCA/DPPA-2 is also a possible cancer stem cell marker. One can determine presence of cancer by assaying for the molecule, and also prevent or treat cancer via administration of the molecule.
    Type: Application
    Filed: October 2, 2007
    Publication date: August 19, 2010
    Applicant: LUDWIG INSTITUTE FOR CONCER RESEARCH
    Inventors: Thomas John, Suzanne Svobodova, Jonathan Cebon, Otavia L. Caballero, Marilyn Monk